scholarly journals Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in J apanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover study

2015 ◽  
Vol 17 (8) ◽  
pp. 800-804 ◽  
Author(s):  
R. Nishimura ◽  
T. Osonoi ◽  
S. Kanada ◽  
H. Jinnouchi ◽  
K. Sugio ◽  
...  
Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 973-P
Author(s):  
ALLISON LAROCHE ◽  
KRISTINA UTZSCHNEIDER ◽  
CATHERINE PIHOKER

Sign in / Sign up

Export Citation Format

Share Document